An increased incidence of rejection episodes: One of the causes of worse kidney transplantation survival in black recipients

Archives of Surgery

Volumn 132, Issue 1, 1997, Pages 35-40

  Tesi, Raymond J ^a   Deboisblanc, Michael ^a   Saul, Chad ^a   Frentz, Gary ^a   Etheredge, Edward ^a  

^a TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ARTICLE; GRAFT SURVIVAL; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL;

EID: 0031013555     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430250037007     Document Type: Article

References (33)

1. Welter JM, Wu SC, Ferguson CW, Port FK. Influence of race of cadaveric kidney donor and recipient on graft survival: a multifactorial analysis. Am J Kidney Dis. 1987;9:191-199.
2. Diethelm AG, Blackstone EH, Naftel DC, et al. Important risk factors of allograft survival in cadaveric renal transplantation: a study of 426 patients. Ann Surg. 1988;207:538-548.
3. Garvin PJ, Castaneda M, Codd JE, Mauller K. Recipient race as a risk factor in renal transplantation. Arch Surg. 1983;118:1441-1444.
4. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients: HLA matching and other factors affecting long-term graft survival. Transplantation. 1994;57:1064-1068.
5. Burdick JF, Williams GM. What causes center effects in kidney transplantation. Ann Surg. 1986;203:311-314.
6. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts: overriding effects of HLA matching and socioeconomic factors. N Engl J Med. 1992;327:840-845.
7. Cosio F, Dillion J, Falkenhain M, et al. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995;47:1136-1141.
8. Sumrani NB, Delaney V, Daskalakis P, et al. Retrospective analysis of post-transplantation diabetes mellitus in black renal allograft recipients. Diabetes Care. 1991;14:760-762.
9. Tesi R, deBoisblanc M, Saul C, O'Donovan R, Etheredge E. Donor race does not affect cadaver kidney transplant survival: a single center experience. Transplantation. 1995;60:1401-1406.
10. Van Buren DH, Richie RE, Nylander W, Helderman H, MacDonell RC, Johnson HK. Single-center analysis of impact of immunosuppressive therapy upon renal allograft survival in the black population. South Med J. 1991;84:715-718.
11. Light JA, Kelly JL, Aquino A, Neu L, DeNavas L, Williams K. Improving renal transplant outcomes in African Americans with OKT3 induction therapy. Transplant Proc. 1993;25:2436-2438.
12. Gaston RS, Hudson SL, Deierhoi MH, et al. Improved survival of primary ca daveric renal allografts in blacks with quadruple immunosuppression. Transplantation. 1992;53:103-109.
13. Yong WC, Terasaki P. Long-term survival. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles, Calif: University of California, Los Angeles, Tissue Typing Laboratory; 1988:277-282.
14. Laskow DA, Diethelm AG, Hudson SL, et al. Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles, Calif: University of California, Los Angeles, Tissue Typing Laboratory; 1991:179-191.
15. Delaney V, Ling BN, Campbell WG, et al. Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis. Nephron. 1993:63:263-272.
16. UNOS. 1994 report of center specific graft and patient survival rates. UNOS. 1994;1:1c-125c.
17. US Renal Data Systems. USRDS 1994 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994(pt 2):C.1-J.6.
18. Zhou YC, Cecka JM, Terasaki PI. Effect of race on kidney transplants. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles, Calif: University of California, Los Angeles, Tissue Typing Laboratory; 1990:447-459.
19. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 1993;55:752-757.
20. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation. 1993;56:307-315.
21. Tesi RJ, Henry ML, Elkhammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant. 1993;7:345-352.
22. Lim EC, Terasaki PI. Early graft function. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1991. Los Angeles, Calif: University of California, Los Angeles, Tissue Typing Laboratory; 1992:401-407.
23. Cacciarelli T, Sumrani N, Delaney V, Hong JH, DiBenedetto A, Sommer BG. The influence of delayed renal allograft function on long-term outcome in the cyclosporine era. Clin Nephrol. 1993;39:335-339.
24. Iwaki Y, Terasaki PI. Primary nonfunction in human cadaver kidney transplantation: evidence for hidden hyperacute rejection. Clin Transplant 1987;1:125-131.
25. Henry ML, Sommer BG, Tesi RJ, Ferguson RM. Improved immediate renal allograft function after initial simple cold storage. Transplant Proc. 1990;22:388-389.
26. Tesi RJ, Elkhammas E, Davis E, Henry M, Ferguson R. Pulsatile kidney perfusion for evaluation of high-risk kidney donors safely expands the donor pool. Clin Transplant. 1994;8:134-138.
27. Koyama H, Cecka JM. Race effects. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles, Calif: University of California, Los Angeles, Tissue Typing Laboratory; 1991:269-280.
28. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation. 1991;51:338-342.
29. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences. Transplant Proc. 1991;23:380-382.
30. Sanders CE, Curtis JJ, Julian BA, et al. Tapering or discontinuing cyclosporine for financial reasons: a single-center experience. Am J Kidney Dis. 1993;21:9-15.
31. Tornatore KM, Reed KA, Venuto RC. Racial differences in the pharmacokinetics of methylprednisolone in black and white renal transplant recipients. Pharmacotherapy. 1993;13:481-486.
32. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of XX pregnancy treated by orthotopic liver transplantation. Hepatology. 1990;11:59-64.
33. Takemoto S, Terasaki PI, Gjertson DW, Cecka JM. Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med. 1994;331:760-764.